Clinical trial
Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation…
NCT00146640 · Merck KGaA, Darmstadt, Germany, Industry · Completed
Key facts
| NCT number | NCT00146640 |
|---|---|
| Title | Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis |
| Official title | A New Timed-Release Tablet Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis- A Randomized, Multi-Centre, Double-Blind, Active Controlled Study With Open Extension on the New Drug Only |
| Lead sponsor | Merck KGaA, Darmstadt, Germany, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | MR Prednisone, IR Prednisone, Placebo - MR Prednisone, Placebo - IR Prednisone |
| Enrollment | 288 |
| Start date | Aug 31, 2004 |
| Primary completion | Jan 31, 2007 |
| Completion | Jan 31, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Jul 3, 2018 |
| Countries | Germany, Poland |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: